SPDYE11
gene geneOn this page
Summary
SPDYE11 (speedy/RINGO cell cycle regulator family member E11, HGNC:51507) is a protein-coding gene on chromosome 7q11.23, encoding Speedy protein E11 (P0DTA3). Acts as a modulator of the nicotinic acetylcholine receptor alpha-7 (CHRNA7) activity.
Enables acetylcholine receptor regulator activity.
Source: NCBI Gene 100996746 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001351349
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51507 |
| Approved symbol | SPDYE11 |
| Name | speedy/RINGO cell cycle regulator family member E11 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000275976 |
| Ensembl biotype | protein_coding |
| Entrez | 100996746 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 retained_intron
ENST00000340073, ENST00000573748
RefSeq mRNA: 2 — MANE Select: NM_001351349
NM_001351349, NM_001422015
CCDS: CCDS94115
Canonical transcript exons
ENST00000340073 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002441325 | 73057790 | 73057911 |
| ENSE00002444054 | 73047862 | 73049343 |
| ENSE00002475456 | 73055982 | 73056564 |
| ENSE00002495080 | 73054774 | 73054992 |
| ENSE00002519509 | 73053682 | 73053740 |
| ENSE00003844875 | 73050197 | 73050301 |
| ENSE00003847040 | 73050424 | 73050667 |
| ENSE00003847951 | 73052369 | 73052454 |
Expression profiles
Bgee: expression breadth ubiquitous, 127 present calls, max score 77.02.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| urinary bladder | UBERON:0001255 | 77.02 | gold quality |
| bone marrow cell | CL:0002092 | 65.98 | silver quality |
| colonic epithelium | UBERON:0000397 | 64.65 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 64.60 | gold quality |
| bone marrow | UBERON:0002371 | 63.10 | silver quality |
| monocyte | CL:0000576 | 62.43 | gold quality |
| stromal cell of endometrium | CL:0002255 | 61.93 | gold quality |
| leukocyte | CL:0000738 | 61.82 | gold quality |
| ganglionic eminence | UBERON:0004023 | 59.85 | gold quality |
| ventricular zone | UBERON:0003053 | 59.73 | gold quality |
| right testis | UBERON:0004534 | 57.54 | gold quality |
| cortical plate | UBERON:0005343 | 57.39 | silver quality |
| testis | UBERON:0000473 | 56.45 | gold quality |
| left testis | UBERON:0004533 | 56.16 | gold quality |
| liver | UBERON:0002107 | 56.15 | gold quality |
| blood | UBERON:0000178 | 55.64 | gold quality |
| calcaneal tendon | UBERON:0003701 | 55.37 | gold quality |
| granulocyte | CL:0000094 | 55.29 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 54.34 | silver quality |
| adrenal tissue | UBERON:0018303 | 54.25 | gold quality |
| prefrontal cortex | UBERON:0000451 | 53.78 | gold quality |
| muscle of leg | UBERON:0001383 | 53.59 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 53.56 | gold quality |
| lymph node | UBERON:0000029 | 53.26 | gold quality |
| gastrocnemius | UBERON:0001388 | 52.89 | gold quality |
| kidney | UBERON:0002113 | 52.82 | gold quality |
| tonsil | UBERON:0002372 | 52.69 | gold quality |
| cortex of kidney | UBERON:0001225 | 52.50 | gold quality |
| placenta | UBERON:0001987 | 52.08 | gold quality |
| frontal cortex | UBERON:0001870 | 51.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spdye4b | ENSMUSG00000029586 |
| mus_musculus | Spdye4a | ENSMUSG00000039296 |
| rattus_norvegicus | Spdye4 | ENSRNOG00000058563 |
Paralogs (18): SPDYE1 (ENSG00000136206), SPDYE5 (ENSG00000170092), SPDYE2B (ENSG00000173678), SPDYE4 (ENSG00000183318), SPDYE12 (ENSG00000184616), SPDYE16 (ENSG00000185040), SPDYE17 (ENSG00000186645), SPDYE2 (ENSG00000205238), SPDYE18 (ENSG00000205482), SPDYE3 (ENSG00000214300), SPDYE21 (ENSG00000230358), SPDYE6 (ENSG00000260097), SPDYE9 (ENSG00000262461), SPDYE8 (ENSG00000273520), SPDYE10 (ENSG00000274570), SPDYE15 (ENSG00000286014), SPDYE13 (ENSG00000286038), SPDYE14 (ENSG00000286137)
Protein
Protein identifiers
Speedy protein E11 — P0DTA3 (reviewed: P0DTA3)
All UniProt accessions (1): P0DTA3
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a modulator of the nicotinic acetylcholine receptor alpha-7 (CHRNA7) activity.
Similarity. Belongs to the Speedy/Ringo family.
RefSeq proteins (2): NP_001338278, NP_001408944 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020984 | Speedy | Family |
| IPR057742 | Speedy_E | Family |
Pfam: PF11357
UniProt features (3 total): chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DTA3-F1 | 70.55 | 0.42 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 4 (showing top):
chr7q11, GOMF_KINASE_BINDING, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, GOMF_NEUROTRANSMITTER_RECEPTOR_REGULATOR_ACTIVITY
GO Biological Process (1): positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)
GO Molecular Function (2): protein kinase binding (GO:0019901), acetylcholine receptor regulator activity (GO:0030548)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of cyclin-dependent protein serine/threonine kinase activity | 1 |
| cyclin-dependent protein serine/threonine kinase activity | 1 |
| positive regulation of cell cycle | 1 |
| positive regulation of protein serine/threonine kinase activity | 1 |
| positive regulation of cyclin-dependent protein kinase activity | 1 |
| kinase binding | 1 |
| acetylcholine receptor activity | 1 |
| neurotransmitter receptor regulator activity | 1 |
Protein interactions and networks
STRING
2134 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPDYE11 | ZDHHC11B | P0C7U3 | 576 |
| SPDYE11 | ZFP30 | Q9Y2G7 | 507 |
| SPDYE11 | ZNF512 | Q96ME7 | 479 |
| SPDYE11 | TBL3 | Q12788 | 438 |
| SPDYE11 | DDX49 | Q9Y6V7 | 415 |
| SPDYE11 | MICALL1 | Q8N3F8 | 400 |
| SPDYE11 | SACK1B | Q5T0W9 | 400 |
| SPDYE11 | DNAH8 | Q96JB1 | 370 |
| SPDYE11 | EIF3L | Q9Y262 | 366 |
| SPDYE11 | RPS5 | P46782 | 334 |
| SPDYE11 | EPRS1 | P07814 | 304 |
| SPDYE11 | YARS1 | P54577 | 277 |
| SPDYE11 | ZBTB34 | Q8NCN2 | 272 |
| SPDYE11 | FKBP8 | Q14318 | 271 |
| SPDYE11 | ZC3H12A | Q5D1E8 | 225 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0J9YY54, A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NNV3, B4DH59, F6SZT2, P0C6Y7, P0CI01, P0DKJ7, P0DKJ8, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, P79386, Q08AG5, Q13342, Q16666, Q3BBV2, Q495Y8, Q587J8, Q5JRC9, Q5QGU6, Q5RD14, Q5RKG3, Q63HK3, Q6ITT4, Q7TQI8, Q86T75, Q8IWY8, Q8N660, Q8NFV5
Diamond homologs: A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NKU9, A6NLX3, A6NNV3, P0CI01, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, Q495Y7, Q495Y8, Q5IBH6, Q5IBH7, Q5MJ68, Q5MJ70, Q8NFV5, Q8R496, Q9PU13, Q9YGL1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1742 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1156452073 (7:73055330 G>C), RS1159915971 (7:73055607 CT>C,CTT), RS1163745417 (7:73055619 CTTTTTTTTTTTTT>C,CT,CTT,CTTTT,CTTTTT,CTTTTTT,CTTTTTTT,CTTTTTTTT,CTTTTTTTTT,CTTTTTTTTTT,CTTTTTTTTTTT,CTTTTTTTTTTTT,CTTTTTTTTTTTTTT,CTTTTTTTTTTTTTTT,CTTTTTTTTTTTTTTTT,CTTTTTTTTTTTTTTTTTTTTTTTT), RS1170369935 (7:73055688 G>A), RS1174870716 (7:73055985 A>C), RS1175595565 (7:73055263 C>A,G,T), RS1177920690 (7:73056045 G>T), RS1178509833 (7:73056019 G>A), RS1179166425 (7:73050149 G>A), RS1183440432 (7:73055347 G>T), RS1186395929 (7:73055622 T>C), RS1197794310 (7:73055707 C>G), RS1198090804 (7:73052215 C>T), RS1198511605 (7:73049697 G>A), RS1201647232 (7:73056070 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.